Medical News: Chemo Duo Called New Standard for Biliary CA - in Hematology/Oncology, Chemotherapy from MedPage Today

Links shared publicly online about this topic.

  • 1,257
    total visits

Medical News: Chemo Duo Called New Standard for Biliary CA - in Hematology/Oncology, Chemotherapy from MedPage Today

medpagetoday.com —

Adding cisplatin to standard gemcitabine (Gemzar) extends survival in biliary tract cancer without added toxicity, according to results of a phase III clinical trial.

View full resource at medpagetoday.com

Tags: Cancer, Cancer Medication, Chemotherapy, Clinical Trial, Gemzar

  • Share

Most Recently Shared on April 8, 2010 at 10:23 pm By:

teamoncology Naoto T. Ueno

Cisplatin+Gemcitabine extended survival in biliary tract #cancer without added toxicity in a phase III trial. NEJM http://bit.ly/b0oW11

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

FightCancer FightCancer

Advertisement